Get expert advice from NIA and BIO as you develop your SBIR/STTR.
Are you planning to apply for non-dilutive funding to advance your aging-related research? Join the National Institutes of Health’s National Institute on Aging (NIA) Office of Small Business Research (OSBR) and Biotechnology Innovation Organization (BIO) on Tuesday, June 29, 2021, at 2 p.m. ET for the 2021 NIH-BIOConnections Summer Series. This four-part workshop will highlight NIH’s Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs across three NIH institutes and centers and highlight the efforts and resources to improve the diversity of the research workforce.
Join us as we kick off the 2021 NIH-BIOConnections Summer Series on Tuesday, June 29, at 2 p.m. ET with our first webinar, Driving Aging Innovations through Commercialization. OSBR Director Todd Haim, Ph.D., will provide an overview of the SBIR/STTR programs, guidance on drafting a competitive application, and additional resources to help you advance your research. Michele Oshan, BIO’s VP of External Relations will discuss the importance of SBIR to the bioeconomy and applicants can get involved.
Through education, collaboration, and advocacy, BIO strives to drive a bio-revolution that cures patients, protects our climate, and nourishes humanity. BIO is proud to host a portfolio of partnering conferences that not only unite and empower biotech innovators and their ecosystem to improve lives, but also offer a broad and unbiased venue to seek investment and business development and licensing (BD&L) opportunities.
We join BIO in inviting entrepreneurial researchers, small businesses, and research organizations to take this opportunity to learn how to tap into NIA’s SBIR and STTR programs, which can help accelerate research on innovations in Alzheimer’s disease, Alzheimer’s disease-related dementias, and other diseases of aging.
Featured Speakers
We encourage individuals from the following groups to attend:
Mark your calendar now for these upcoming sessions in the series:
NIA, one of the 27 Institutes and Centers of NIH, leads a broad scientific effort to understand the nature of aging and to extend the healthy, active years of life. NIA is the primary Federal agency supporting and conducting Alzheimer's disease research.
The Biotechnology Innovation Organization (BIO) is the world’s largest advocacy association representing member companies, state biotechnology groups, academic and research institutions, and related organizations across the United States and in 30+ countries. As a proactive voice OF SCIENCE and FOR SCIENCE, we are driving a revolution to cure patients, protect our climate, and nourish humanity. BIO is committed to speaking up for the millions of families around the globe who depend upon our success. We will drive a revolution that aims to cure patients, protect our climate, and nourish humanity.
NCATS’ SBIR and STTR programs are engines of innovation for developing and commercializing tools, technologies and intervention platforms to support the creation of new therapeutics and diagnostics. SBIR and STTR are government set-aside programs for domestic small businesses to engage in research and development that has the potential for commercialization and public benefit.
The National Institute on Alcohol Abuse and Alcoholism conducts and supports research to expand and disseminate fundamental knowledge about the effects of alcohol on health and well-being, and applies that knowledge to improve diagnosis, prevention, and treatment of alcohol-related problems, including alcohol use disorder, across the lifespan.